September 29, 2008
ZLB Plasma Licenses Mediware’s RecruitTrak(TM) for 65 Facilities
Mediware Information Systems, Inc. (NASDAQ: MEDW) announced that ZLB Plasma has licensed the Company's RecruitTrak(TM) software to support plasma donor recruitment in 65 plasma centers throughout the United States. RecruitTrak, which is one of Mediware's Blood Center Technologies (BCT) products, provides a powerful online environment to enable ZLB staff to better manage donor relationships, increase recruitment efforts and lengthen donor retention.
RecruitTrak will provide ZLB Plasma CRM technologies focused on improving donor recruitment and retention. Key features for ZLB Plasma include RecruitTrak's powerful email and direct mail marketing integration as well as an online 'donor store' that rewards repeat donors and improves retention.
"Recruiting new donors and retaining our existing community is essential for ZLB Plasma," said Scott Newkirk, ZLB Plasma's Director of Marketing. "We needed a proven solution that could accommodate the scale of our business nationwide. I am very excited about our RecruitTrak implementation and look forward to working with Mediware to extend our capabilities."
RecruitTrak provides a comfortable online environment for donors to stay in touch and view their donation histories, eligibility and online store point standings. The product also allows blood and plasma center staff with the tools to easily send regular email or direct mail messages to the donor community, market upcoming special events and monitor donor performance against marketing plans and demand schedules.
"I am very pleased to welcome ZLB Plasma to our growing community of customers," said Kelly Mann, Mediware's president and chief executive officer. "With more than 350 blood center customers, expansion into plasma centers is an exciting area of focus and potential growth for Mediware. I look forward to announcing further developments within this adjacent market in the future."
RecruitTrak is part of Mediware's BCT family of products which also includes:
-- CoordinatorTrak(TM), Motivates drive coordinators with tools that save time and build loyalty; -- OrderTrak(TM), Enables online ordering of blood products for hospitals; -- QualityTrak(TM), Captures donor satisfaction statistics to enhance customer service; -- CallTrak(TM), Improves the efficiency and effectiveness of telerecruitment programs; -- DriveTrak(TM), Manages mobile drive recruitment including staff scheduling; -- SalesTrak(TM), Maximizes sales prospects through comprehensive customer and pipeline management; and -- LifeTrak(R), a 510(k) cleared donor management system that manages donor eligibility, manufacturing and distribution for many of the largest blood suppliers, testing facilities and centralized transfusion services (CTS).
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site.
About ZLB Plasma
ZLB Plasma, one of the largest collectors of human plasma in the world, is dedicated to the collection of plasma for life-saving therapies. ZLB Plasma operates plasma collection centers across the United States and Germany. The Company is part of the CSL Behring group that is owned by CSL Limited, based in Australia. The group has a proud heritage dating back to the scientific efforts of Nobel Prize winner Emil von Behring and the renowned efforts of the Swiss Red Cross. CSL Ltd. was founded in Melbourne, Australia, in 1916 to supply vaccines for the Australian Government. CSL has grown rapidly through strategic acquisitions and investment to become a successful global specialty biopharmaceutical company with over 8,000 associates in 19 countries.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2008, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
Contact: John Van Blaricum 913.307.1017
SOURCE: Mediware Information Systems